Tango Therapeutics Inc.(TNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TNGX Tango Therapeutics Inc.

已收盘 11-03 16:00:00 EST

23.17

+1.41

+6.48%

盘后23.17

+0.000.00%

19:30 EST

最高23.98	最低21.99	成交量245.81万
今开22.09	昨收21.76	日振幅9.15%
总市值39.16亿	流通市值28.04亿	总股本1.69亿
成交额5,734万	换手率2.03%	流通股本1.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TNGX","market":"US","secType":"STK","nameCN":"Tango Therapeutics Inc.","latestPrice":23.17,"timestamp":1793739600000,"preClose":21.76,"halted":0,"volume":2458055,"hourTrading":{"tag":"盘后","latestPrice":23.17,"preClose":23.17,"latestTime":"19:30 EST","volume":29428,"amount":681846.3201,"timestamp":1793752204625,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.06479779411764706,"floatShares":121000000,"shares":169000000,"eps":-0.84,"marketStatus":"已收盘","change":1.41,"latestTime":"11-03 16:00:00 EST","open":22.09,"high":23.98,"low":21.99,"amount":57342799.97693,"amplitude":0.091452,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.84,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793782800000},"marketStatusCode":5,"adr":0,"listingDate":1599105600000,"exchange":"NASDAQ","adjPreClose":21.76,"preHourTrading":{"tag":"盘前","latestPrice":21.22,"preClose":21.76,"latestTime":"08:06 EST","volume":274,"amount":6042.890256,"timestamp":1793711205597,"change":-0.54,"changeRate":-0.024816,"amplitude":0.104779},"postHourTrading":{"tag":"盘后","latestPrice":23.17,"preClose":23.17,"latestTime":"19:30 EST","volume":29428,"amount":681846.3201,"timestamp":1793752204625,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.648085,"impliedVol":0.8719,"impliedVolPercentile":0.5259},"requestUrl":"/m/hq/s/TNGX","defaultTab":"news","newsList":[{"id":"1199057484","title":"异动解读｜Tango Therapeutics Inc.盘中下跌12.1%，胰腺癌早期试验数据发布后市场分歧加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1199057484","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199057484?lang=zh_cn&edition=full","pubTime":"2026-10-24 00:56","pubTimestamp":1792774614,"startTime":"0","endTime":"0","summary":"10月24日，Tango Therapeutics Inc.盘中下跌12.1%，报24.545美元，成交额2.53亿美元。不过，安全性方面，40%的安全性可评估患者出现3级治疗相关不良反应；公司同时表示，计划于明年上半年启动针对MTAP缺失胰腺癌的一项全球随机Ⅲ期试验。数据虽积极，但早期试验属性与安全性指标令市场交易情绪出现分化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"胰腺癌早期数据亮眼，Tango股价却遭重挫","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128211583","title":"Tango Therapeutics 高管变动：Barbara Weber 执行主席职务于2026年8月3日终止——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1128211583","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128211583?lang=zh_cn&edition=full","pubTime":"2026-08-07 05:35","pubTimestamp":1786052151,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc.近期向美国证券交易委员会（SEC）提交了一份文件。这份文件明确显示，Barbara Weber 担任公司执行主席一职的雇佣关系，已于2026年8月3日正式终止。这一人事变动，已被正式记录并对外公开。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111438000","title":"异动解读｜Tango Therapeutics盘中下跌8.44%，报28.4美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111438000","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111438000?lang=zh_cn&edition=full","pubTime":"2026-07-14 02:01","pubTimestamp":1783965704,"startTime":"0","endTime":"0","summary":"7月14日，Tango Therapeutics盘中下跌8.44%，报28.4美元/股，成交额4077.36万美元。Tango Therapeutics所在的生物科技行业中，个股中，艾吉纳斯公司涨99.4%，Q32 Bio Inc.涨75.78%，阿尔尼拉姆制药公司跌4.02%，艾伯维公司跌0.47%，Moderna, Inc.跌0.88%。Tango Therapeutics Inc.是一家临床阶段生物技术公司，致力于发现新的药物靶点并提供用于治疗癌症的下一代精准医学，利用合成致死的遗传原理来发现和开发针对癌症关键靶点的疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125319993","title":"Tango Therapeutics：Vopimetostat联合Daraxonrasib总体耐受性良好，未出现新的安全性信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1125319993","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125319993?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:00","pubTimestamp":1780916427,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc. 公布的数据显示，其药物Vopimetostat与Daraxonrasib联合疗法的安全性特征总体良好。在临床研究中，该联合方案未引发新的安全性问题，耐受性表现符合预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192369659","title":"Tango Therapeutics 将推进Vopimetostat联合Daraxonrasib进入针对MTAP缺失胰腺癌的三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1192369659","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192369659?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:00","pubTimestamp":1780916423,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc. 宣布，其药物组合Vopimetostat与Daraxonrasib将进入针对MTAP缺失型胰腺癌的第三阶段临床研究。这一进展标志着该公司在精准肿瘤学领域的重要一步，旨在为这种特定基因亚型的胰腺癌患者探索新的治疗可能性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173708738","title":"异动解读 | Tango Therapeutics盘中大跌10.11%，因Piper Sandler下调评级至“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=1173708738","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173708738?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:10","pubTimestamp":1778854204,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc.今日盘中股价大跌10.11%，引起了市场的广泛关注。消息面上，华尔街分析师对公司评级和目标价进行了调整，其中Piper Sandler将Tango Therapeutics的股票评级从“增持”下调至“中性”，这通常被视为负面信号，可能是导致股价承压的主要原因。与此同时，另一家机构Leerink Partners则大幅上调了Tango Therapeutics的目标价，从28美元上调至55美元，显示出分析师观点存在分歧。然而，市场在交易中似乎更侧重于对评级下调的负面解读，从而引发了此次股价的大幅下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119086902","title":"异动解读 | Tango Therapeutics盘前大跌9.73%，因Piper Sandler下调评级至“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=1119086902","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119086902?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:28","pubTimestamp":1778833680,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc.今日盘前股价大幅下挫9.73%，引起了市场关注。其中，Piper Sandler将Tango Therapeutics的股票评级从“增持”下调至“中性”，这通常被视为负面信号，可能是导致股价承压的主要原因。尽管该机构同时将目标价从16美元上调至24美元，但评级下调往往对投资者情绪产生更直接的影响。与此同时，另一家机构Leerink Partners则大幅上调了Tango Therapeutics的目标价，从28美元上调至55美元，显示出分析师观点存在分歧。然而，市场在盘前交易中似乎更侧重于对评级下调的负面解读。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125933311","title":"异动解读 | 杰富瑞下调评级，Tango Therapeutics盘中大跌10.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125933311","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125933311?lang=zh_cn&edition=full","pubTime":"2026-05-15 00:58","pubTimestamp":1778777917,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc.（股票代码：TNGX）今日盘中股价大幅下挫10.82%，引起了市场的广泛关注。消息面上，根据路透社报道，华尔街知名投行杰富瑞（Jefferies）将该公司的股票评级从“买入”下调至“持有”。尽管杰富瑞同时将目标价从18美元上调至27美元，但评级的下调通常被市场解读为分析师对公司短期前景转为谨慎，这可能是引发股价盘中大幅下跌的主要原因。市场对主要投行的评级变动反应敏感，尤其是在交易时段内。此次杰富瑞的评级调整反映了其对Tango Therapeutics的最新看法，并直接影响了投资者的短期交易决策，导致抛压加剧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173020765","title":"异动解读 | 杰富瑞下调评级，Tango Therapeutics盘前大跌6.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173020765","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173020765?lang=zh_cn&edition=full","pubTime":"2026-05-14 20:28","pubTimestamp":1778761732,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc.（股票代码：TNGX）今日盘前股价大幅下挫6.70%，引起了市场的关注。消息面上，根据路透社报道，华尔街券商杰富瑞（Jefferies）将该公司的股票评级从“买入”下调至“持有”。尽管杰富瑞同时将目标价从18美元上调至27美元，但评级的下调通常被市场解读为分析师对公司短期前景转为谨慎，这可能是引发股价下跌的主要原因。评级调整反映了分析师对该公司的最新看法，并可能影响投资者的短期交易决策。市场通常对主要投行的评级变动反应敏感，尤其是在盘前交易时段。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518271986","title":"Tango Therapeutics, Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518271986?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:13","pubTimestamp":1741619611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时13分，Tango Therapeutics, Inc.股票出现波动，股价急速跳水5.22%。截至发稿，该股报1.91美元/股，成交量19.5156万股，换手率0.18%，振幅5.97%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3579.63%、960.54%、798.00%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231331abf32200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231331abf32200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517458219","title":"Tango Therapeutics, Inc.2024财年实现净利润-1.30亿美元，同比减少27.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517458219?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363238,"startTime":"0","endTime":"0","summary":"3月8日，Tango Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少27.45%；其中营业收入为42.07百万美元，同比增加15.17%，每股基本收益为-1.19美元。从资产负债表来看，Tango Therapeutics, Inc.总负债1.29亿美元，其中短期债务2.45百万美元，资产负债比为2.56，流动比率为0.07。机构评级：截至2025年3月8日，当前有7家机构对Tango Therapeutics, Inc.目标价做出预测，其中目标均价为11.29美元，其中最低目标价为8.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000049a2647e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000049a2647e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517469959","title":"Tango Therapeutics, Inc.盘中异动 早盘快速拉升9.78%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517469959?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185061,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Tango Therapeutics, Inc.股票出现波动，股价急速上涨9.78%。截至发稿，该股报2.02美元/股，成交量2625股，换手率0.00%，振幅3.26%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为310.97%、251.30%、183.95%，振幅较大的相关个股有Aditxt, Inc.、4D Molecular Therapeutics, Inc.、Creative Medical Technology Holdings, Inc.，振幅分别为10.04%、8.56%、8.18%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223102989d45ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223102989d45ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516654942","title":"Tango Therapeutics, Inc.盘中异动 股价大跌5.07%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516654942?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:13","pubTimestamp":1741025605,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时13分，Tango Therapeutics, Inc.股票出现波动，股价大幅下挫5.07%。截至发稿，该股报1.97美元/股，成交量41.0267万股，换手率0.38%，振幅12.18%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4355.52%、186.47%、179.12%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021325a25d804f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021325a25d804f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TNGX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332991","title":"Tango Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514332991?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:13","pubTimestamp":1740687198,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时13分，Tango Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。截至发稿，该股报2.21美元/股，成交量29.9409万股，换手率0.28%，振幅7.30%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1921.60%、352.62%、189.60%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228041318abdfb94e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228041318abdfb94e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188823441","title":"探戈治疗公司2024年第四季度GAAP每股收益$(0.35)低于预期$(0.34)，销售额为$4.12百万低于预期$7.77百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1188823441","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188823441?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:12","pubTimestamp":1740658358,"startTime":"0","endTime":"0","summary":"探戈治疗有限公司报告称，季度每股亏损$，低于分析师普遍预期的$，差距为2.94%。相比去年同期销售额$5.43百万，下降了24.19%。以上内容来自Benzinga Earnings专栏，原文如下：Tango $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 2.94 percent. This is a 9.37 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $4.12 million which missed the analyst consensus estimate of $7.77 million by 46.99 percent.  This is a 24.19 percent decrease over sales of","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514381851","title":"Tango Therapeutics, Inc.盘中异动 早盘股价大涨5.00%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514381851?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:03","pubTimestamp":1740582197,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时03分，Tango Therapeutics, Inc.股票出现波动，股价大幅拉升5.00%。截至发稿，该股报2.42美元/股，成交量8.8658万股，换手率0.08%，振幅7.83%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4654.73%、159.89%、143.13%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为155.93%、39.47%、29.31%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262303179893b120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262303179893b120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512652951","title":"Tango Therapeutics, Inc.盘中异动 股价大涨5.67%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512652951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512652951?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889526,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Tango Therapeutics, Inc.股票出现异动，股价大幅拉升5.67%。截至发稿，该股报2.61美元/股，成交量1.9789万股，换手率0.02%，振幅5.47%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为296.68%、102.78%、80.51%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223847962798f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223847962798f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511526364","title":"Tango Therapeutics, Inc.盘中异动 早盘股价大涨5.28%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511526364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511526364?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:39","pubTimestamp":1739457581,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时39分，Tango Therapeutics, Inc.股票出现波动，股价快速上涨5.28%。截至发稿，该股报2.59美元/股，成交量2.8443万股，换手率0.03%，振幅3.25%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1021.41%、966.72%、173.76%，振幅较大的相关个股有Moleculin Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Edesa Biotech, Inc.，振幅分别为56.19%、32.86%、30.10%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223942abcdb3c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223942abcdb3c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TNGX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510555331","title":"Tango Therapeutics, Inc.盘中异动 股价大跌5.10%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510555331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510555331?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:28","pubTimestamp":1739291317,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时28分，Tango Therapeutics, Inc.股票出现异动，股价大幅下跌5.10%。截至发稿，该股报2.59美元/股，成交量30.9105万股，换手率0.29%，振幅3.48%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.57%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2833.79%、1269.78%、421.52%，振幅较大的相关个股有Ocean Biomedical, Inc.、Dominari Holdings Inc.、Omega Therapeutics, Inc.，振幅分别为59.46%、58.60%、49.17%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120028379881d159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120028379881d159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510007893","title":"Tango Therapeutics, Inc.盘中异动 股价大跌5.12%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510007893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510007893?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:08","pubTimestamp":1739210886,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时08分，Tango Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。截至发稿，该股报2.88美元/股，成交量28.4781万股，换手率0.27%，振幅5.12%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Springworks Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3013.28%、1630.30%、1297.77%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211020806abc9d3ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211020806abc9d3ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TNGX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tangotx.com","stockEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.0637},{"period":"3month","weight":-0.2589},{"period":"6month","weight":-0.0787},{"period":"1year","weight":1.6831},{"period":"ytd","weight":1.456}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tango Therapeutics Inc.于2020年5月21日在特拉华州注册成立，是一家生物技术公司，致力于发现新的药物靶点并提供用于治疗癌症的下一代精准医学。Tango采用一种以患者为起点和终点的方法，利用合成致死的遗传原理来发现和开发针对癌症关键靶点的疗法。这包括将精确肿瘤学目标的范围扩展到新领域，例如肿瘤抑制基因丢失及其对癌细胞逃避免疫细胞杀伤能力的贡献。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.023682},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.080779},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.037879},{"month":4,"riseRate":0.5,"avgChangeRate":-0.014096},{"month":5,"riseRate":0.333333,"avgChangeRate":0.025165},{"month":6,"riseRate":0.833333,"avgChangeRate":0.315204},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000171},{"month":8,"riseRate":0.833333,"avgChangeRate":0.206007},{"month":9,"riseRate":0.666667,"avgChangeRate":0.120644},{"month":10,"riseRate":0.142857,"avgChangeRate":0.071773},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.032874},{"month":12,"riseRate":0.5,"avgChangeRate":-0.005187}],"exchange":"NASDAQ","name":"Tango Therapeutics Inc.","nameEN":"Tango Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tango Therapeutics Inc.(TNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tango Therapeutics Inc.(TNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tango Therapeutics Inc.,TNGX,Tango Therapeutics Inc.股票,Tango Therapeutics Inc.股票老虎,Tango Therapeutics Inc.股票老虎国际,Tango Therapeutics Inc.行情,Tango Therapeutics Inc.股票行情,Tango Therapeutics Inc.股价,Tango Therapeutics Inc.股市,Tango Therapeutics Inc.股票价格,Tango Therapeutics Inc.股票交易,Tango Therapeutics Inc.股票购买,Tango Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tango Therapeutics Inc.(TNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tango Therapeutics Inc.(TNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}